
Identification
Properties
Safety Data
Specifications and Other Information
Links
Identification
CAS Number
60239-18-1
Name
DOTA
Synonyms
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1,4,7,10-tetraazacyclododecane dodecane-1,4,7,10-tetraacetic acid
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid [ACD/Index Name]
1,4,7,10-Tetraazacyclododecane-N,N’,N”,N”’-tetraacetic acid
2,2′,2”,2”’-(1,4,7,10-Tetraazacyclododecan-1,4,7,10-tetrayl)tetraessigsäure [German] [ACD/IUPAC Name]
2,2′,2”,2”’-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid [ACD/IUPAC Name]
60239-18-1 [RN]
Acide 2,2′,2”,2”’-(1,4,7,10-tétraazacyclododécane-1,4,7,10-tétrayl)tetraacétique [French] [ACD/IUPAC Name]
DOTA [Wiki]
Tetraxetan [USAN]
[60239-18-1]
1,4,7,10-Dota
1,4,7,10-tetra(carboxymethyl)-1,4,7,10-tetraazacyclododecane
1,4,7,10-tetraazacyclododecane – 1,4,7,10-tetraacetic acid
1,4,7,10-Tetraazacyclododecane-1,4,7,10-TetraaceticAcid
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakisacetic acid
1,4,7,10-tetraazacylododeane-1,4,7,10-tetraacetic acid
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
2,2′,2′,2”’-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid
2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]ethanoic acid
D06092
Dota acid
DOTA/Tetraxetan/1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid
MFCD00068657
NSC 681107
Tetraxetan (USAN)
TPC-M004
UNII-1HTE449DGZ
Molecular Structure
C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O
StdInChI
InChI=1S/C16H28N4O8/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28)
StdInChIKey
WDLRUFUQRNWCPK-UHFFFAOYSA-N
Molecular Formula
C16H28N4O8
Molecular Weight
404.42
Beilstein Registry Number
1186987
MDL Number
MFCD00068657
Properties
Appearance
White powder
Specifications and Other Information of Our DOTA CAS 60239-18-1
Standard
Enterprise standard
Identification Methods
HNMR/IR
Purity
98%min
Storage
Under the room temperature and away from light
Application
Used as the pharmaceutical intermediates of Gadoterate Meglumine.
Links
This product is developed by our R&D company Caming Pharmaceutical Ltd(http://www.caming.com/), and here is the corresponding linkhttp://www.caming.com/dota-cas-60239-18-1/
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.










